139 related articles for article (PubMed ID: 20876379)
21. Analysis of HHV-6 mutations in solid organ transplant recipients at the onset of cytomegalovirus disease and following treatment with intravenous ganciclovir or oral valganciclovir.
Bounaadja L; Piret J; Goyette N; Boivin G
J Clin Virol; 2013 Sep; 58(1):279-82. PubMed ID: 23871165
[TBL] [Abstract][Full Text] [Related]
22. GCV resistance due to the mutation A594P in the cytomegalovirus protein UL97 is partially reconstituted by a second mutation at D605E.
Ijichi O; Michel D; Mertens T; Miyata K; Eizuru Y
Antiviral Res; 2002 Feb; 53(2):135-42. PubMed ID: 11750939
[TBL] [Abstract][Full Text] [Related]
23. Sequence and transcriptional analysis of the guinea pig cytomegalovirus UL97 homolog.
Fox DS; Schleiss MR
Virus Genes; 1997; 15(3):255-64. PubMed ID: 9482591
[TBL] [Abstract][Full Text] [Related]
24. Identification of newly detected, drug-related HCMV UL97- and UL54-mutations using a modified plaque reduction assay.
Fischer L; Sampaio KL; Jahn G; Hamprecht K; Göhring K
J Clin Virol; 2015 Aug; 69():150-5. PubMed ID: 26209398
[TBL] [Abstract][Full Text] [Related]
25. Detection of a UL97 gene mutation conferring ganciclovir resistance in human cytomegalovirus: prevalence of the D605E polymorphism in Korean immunocompromised patients.
Sung H; An D; Lee SO; Choi SH; Kim SH; Chi HS; Kim MN
Ann Clin Lab Sci; 2012; 42(4):429-34. PubMed ID: 23090742
[TBL] [Abstract][Full Text] [Related]
26. Cytomegalovirus UL97 mutations associated with ganciclovir resistance in immunocompromised patients from Argentina.
Sánchez Puch S; Ochoa C; Carballal G; Zala C; Cahn P; Brunet R; Salomón H; Videla C
J Clin Virol; 2004 Jul; 30(3):271-5. PubMed ID: 15135748
[TBL] [Abstract][Full Text] [Related]
27. [Drug susceptibility and UL97 gene mutation analysis of cytomegalovirus in recipients of hematopoietic stem cell transplantation].
Zeng A; Dong D; Cui X; Guo M; Zou D; Fang J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):519-22. PubMed ID: 24752100
[TBL] [Abstract][Full Text] [Related]
28. Generation and characterization of a GCV resistant HCMV UL97-mutation and a drug sensitive UL54-mutation.
Fischer L; Laib Sampaio K; Jahn G; Hamprecht K; Göhring K
Antiviral Res; 2013 Dec; 100(3):575-7. PubMed ID: 24120366
[TBL] [Abstract][Full Text] [Related]
29. Functional regions of the human cytomegalovirus protein pUL97 involved in nuclear localization and phosphorylation of ganciclovir and pUL97 itself.
Michel D; Schaarschmidt P; Wunderlich K; Heuschmid M; Simoncini L; Mühlberger D; Zimmermann A; Pavić I; Mertens T
J Gen Virol; 1998 Sep; 79 ( Pt 9)():2105-12. PubMed ID: 9747718
[TBL] [Abstract][Full Text] [Related]
30. Genetic analysis of a ganciclovir-resistant human cytomegalovirus mutant.
Faizi Khan R; Mori S; Eizuru Y; Kumura Ishii K; Minamishima Y
Antiviral Res; 1998 Dec; 40(1-2):95-103. PubMed ID: 9864050
[TBL] [Abstract][Full Text] [Related]
31. Contribution of next generation sequencing to early detection of cytomegalovirus UL97 emerging mutants and viral subpopulations analysis in kidney transplant recipients.
Garrigue I; Moulinas R; Recordon-Pinson P; Delacour ML; Essig M; Kaminski H; Rerolle JP; Merville P; Fleury H; Alain S
J Clin Virol; 2016 Jul; 80():74-81. PubMed ID: 27214758
[TBL] [Abstract][Full Text] [Related]
32. Detection of human cytomegalovirus mutations associated with ganciclovir resistance in cerebrospinal fluid of AIDS patients with central nervous system disease.
Wolf DG; Lee DJ; Spector SA
Antimicrob Agents Chemother; 1995 Nov; 39(11):2552-4. PubMed ID: 8585743
[TBL] [Abstract][Full Text] [Related]
33. Cytomegalovirus antiviral resistance associated with treatment induced UL97 (protein kinase) and UL54 (DNA polymerase) mutations.
Scott GM; Isaacs MA; Zeng F; Kesson AM; Rawlinson WD
J Med Virol; 2004 Sep; 74(1):85-93. PubMed ID: 15258973
[TBL] [Abstract][Full Text] [Related]
34. Ganciclovir-resistant cytomegalovirus disease after allogeneic stem cell transplantation: pitfalls of phenotypic diagnosis by in vitro selection of an UL97 mutant strain.
Hamprecht K; Eckle T; Prix L; Faul C; Einsele H; Jahn G
J Infect Dis; 2003 Jan; 187(1):139-43. PubMed ID: 12508158
[TBL] [Abstract][Full Text] [Related]
35. Acyclovir is phosphorylated by the human cytomegalovirus UL97 protein.
Talarico CL; Burnette TC; Miller WH; Smith SL; Davis MG; Stanat SC; Ng TI; He Z; Coen DM; Roizman B; Biron KK
Antimicrob Agents Chemother; 1999 Aug; 43(8):1941-6. PubMed ID: 10428917
[TBL] [Abstract][Full Text] [Related]
36. Dynamics of the emergence of a human cytomegalovirus UL97 mutant strain conferring ganciclovir resistance in a pediatric stem-cell transplant recipient.
Göhring K; Feuchtinger T; Mikeler E; Lang P; Jahn G; Handgretinger R; Hamprecht K
J Mol Diagn; 2009 Jul; 11(4):364-8. PubMed ID: 19477945
[TBL] [Abstract][Full Text] [Related]
37. Mutation in the UL97 open reading frame of human cytomegalovirus strains resistant to ganciclovir.
Lurain NS; Spafford LE; Thompson KD
J Virol; 1994 Jul; 68(7):4427-31. PubMed ID: 8207815
[TBL] [Abstract][Full Text] [Related]
38. Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma.
Wolf DG; Smith IL; Lee DJ; Freeman WR; Flores-Aguilar M; Spector SA
J Clin Invest; 1995 Jan; 95(1):257-63. PubMed ID: 7814623
[TBL] [Abstract][Full Text] [Related]
39. Value of a ligase chain reaction assay for detection of ganciclovir resistance-related mutation 594 in UL97 gene of human cytomegalovirus.
Bourgeois C; Sixt N; Bour JB; Pothier P
J Virol Methods; 1997 Sep; 67(2):167-75. PubMed ID: 9300382
[TBL] [Abstract][Full Text] [Related]
40. Lack of resistance-associated mutations in UL54 and UL97 genes of circulating cytomegalovirus strains isolated in a medical center in Taiwan.
Shao PL; Lu MY; Liau YJ; Kao CL; Chang SY; Huang LM
J Formos Med Assoc; 2012 Aug; 111(8):456-60. PubMed ID: 22939665
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
